Financials My Size Inc TEL AVIV STOCK EXCHANGE

Equities

MYSZ

US62844N1090

Software

End-of-day quote TEL AVIV STOCK EXCHANGE
- ILa - Intraday chart for My Size Inc

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization 1 6.606 10.2 12.11 3.931 2.445 2.478
Enterprise Value (EV) 1 6.606 10.2 12.11 3.931 2.445 2.478
P/E ratio -1.21 x - - - - -
Yield - - - - - -
Capitalization / Revenue - 71.8 x 92.5 x 0.88 x 0.35 x 0.25 x
EV / Revenue - 71.8 x 92.5 x 0.88 x 0.35 x 0.25 x
EV / EBITDA - -1,681,769 x -1,154,319 x - - -
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book - - - - - -
Nbr of stocks (in thousands) 9.96 36.2 120 181 453 716.1
Reference price 2 663.2 282.0 101.0 21.76 5.400 3.460
Announcement Date 3/19/20 3/29/21 3/18/22 4/14/23 4/1/24 -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales 1 - 0.142 0.131 4.459 6.996 9.984
EBITDA - -6.064 -10.49 - - -
EBIT 1 - -6.146 -10.58 -8.11 -6.07 -4.821
Operating Margin - -4,328.17% -8,074.05% -181.88% -86.76% -48.29%
Earnings before Tax (EBT) - - - - - -
Net income -5.497 - - - - -
Net margin - - - - - -
EPS -550.0 - - - - -
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/19/20 3/29/21 3/18/22 4/14/23 4/1/24 -
1USD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q2 2024 Q3 2024 Q4
Net sales 1 0.043 - 2.528 0.72 1.29 2.156 2.83 2 2 3
EBITDA -2.7 - - - - - - - - -
EBIT 1 -2.722 - -2.378 -2.492 -1.554 -1.105 -0.919 -1.4 -1.4 -0.95
Operating Margin -6,330.23% - -94.07% -346.11% -120.47% -51.25% -32.47% -70% -70% -31.67%
Earnings before Tax (EBT) - - - - - - - - - -
Net income - -2.026 - - - - - - - -
Net margin - - - - - - - - - -
EPS - -16.00 - - - - - - - -
Dividend per Share - - - - - - - - - -
Announcement Date 3/18/22 11/14/22 4/14/23 5/15/23 8/14/23 11/14/23 4/1/24 - - -
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) - - - - - -
ROA (Net income/ Total Assets) - - - - - -
Assets - - - - - -
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 3/19/20 3/29/21 3/18/22 4/14/23 4/1/24 -
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.46 USD
Average target price
5 USD
Spread / Average Target
+44.51%
Consensus

Quarterly revenue - Rate of surprise